Walgreens severs Theranos partnership
The startup has been struggling to repair its reputation after voiding blood tests, and said though its ‘disappointed’ at the termination, it’s ‘fully committed’ to its patients.
The drug store chain— which stopped sending blood tests to Theranos’ Newark, California lab in February—announced that it will shutter 40 Theranos Wellness Centers in Arizona, making this the latest in a series of setbacks for the once-heralded startup.
Brad Fluegel, Walgreens’ senior vice president and chief health care commercial market development officer, issued the following statement:
In light of the voiding of a number of test results, and as the Centers for Medicare and Medicaid Services (CMS) has rejected Theranos’ plan of correction and considers sanctions, we have carefully considered our relationship with Theranos and believe it is in our customers’ best interests to terminate our partnership.
Free download: Practical tips and advice on how to overcome obstacles
A Theranos spokesman told reporters that the company is still working to comply with federal standards:
Become a Ragan Insider member to read this article and all other archived content.
Sign up today
Already a member? Log in here.
Learn more about Ragan Insider.
